These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24817598)

  • 41. Semiparametric transformation models with time-varying coefficients for recurrent and terminal events.
    Zhao X; Zhou J; Sun L
    Biometrics; 2011 Jun; 67(2):404-14. PubMed ID: 20618309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-inferiority trial design for recurrent events.
    Cook RJ; Lee KA; Li H
    Stat Med; 2007 Nov; 26(25):4563-77. PubMed ID: 17380542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Robust covariate-adjusted log-rank statistics and corresponding sample size formula for recurrent events data.
    Song R; Kosorok MR; Cai J
    Biometrics; 2008 Sep; 64(3):741-750. PubMed ID: 18162107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
    Cheng Y; Shen Y
    Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlling test size while gaining the benefits of an internal pilot design.
    Coffey CS; Muller KE
    Biometrics; 2001 Jun; 57(2):625-31. PubMed ID: 11414593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlated time to event data: Modeling repeated clinical mastitis data from dairy cattle in New York State.
    Schukken YH; Bar D; Hertl J; Gröhn YT
    Prev Vet Med; 2010 Dec; 97(3-4):150-6. PubMed ID: 21035216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sample size calculations for noninferiority trials with Poisson distributed count data.
    Stucke K; Kieser M
    Biom J; 2013 Mar; 55(2):203-16. PubMed ID: 23401289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Semiparametric Regression Estimation for Recurrent Event Data with Errors in Covariates under Informative Censoring.
    Yu H; Cheng YJ; Wang CY
    Int J Biostat; 2016 Nov; 12(2):. PubMed ID: 27497870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The reassessment of trial perspectives from interim data--a critical view.
    Bauer P; Koenig F
    Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blinded sample size recalculation in clinical trials with binary composite endpoints.
    Sander A; Rauch G; Kieser M
    J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simple procedures for blinded sample size adjustment that do not affect the type I error rate.
    Kieser M; Friede T
    Stat Med; 2003 Dec; 22(23):3571-81. PubMed ID: 14652861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The importance of varying the event generation process in simulation studies of statistical methods for recurrent events.
    Metcalfe C; Thompson SG
    Stat Med; 2006 Jan; 25(1):165-79. PubMed ID: 16217859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A note on the sample size determination in two-period repeated measurements crossover design with application to clinical trials.
    Yue LQ; Roach P
    J Biopharm Stat; 1998 Nov; 8(4):577-84. PubMed ID: 9855035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blinded sample size reassessment in non-inferiority and equivalence trials.
    Friede T; Kieser M
    Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
    Li B; Grambsch P
    Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Bayesian approach on sample size calculation for comparing means.
    Wang H; Chow SC; Chen M
    J Biopharm Stat; 2005; 15(5):799-807. PubMed ID: 16078386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonparametric comparison for panel count data with unequal observation processes.
    Zhao X; Sun J
    Biometrics; 2011 Sep; 67(3):770-9. PubMed ID: 21114659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An improved double sampling procedure based on the variance.
    Proschan MA; Wittes J
    Biometrics; 2000 Dec; 56(4):1183-7. PubMed ID: 11129477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.